There are many regulatory and programmatic challenges that will need to be addressed before storing certain vaccines outside of the 2-8°C becomes a feasible practice. However, one of the first issues to tackle is what we call this new storage⁄transport arrangement. While many options have been proposed, we'd like to get input and opinions from as many people as possible before choosing an official term.

[Read more]

Comment on this post by email or on the web

The introduction of the pentavalent vaccine will further eat into the health budget as shown by Natasha Hsi, Abt Associates, Katherine Wolf, Emory University, Global Health Council (Financial Sustainability of Globally Funded Initiatives, June 2, 2005). The study says that, with the introduction of the pentavalent vaccine, the cost of routine immunization tripled. That is, instead of a per capita vaccine expenditure of 0.31$, the cost increased to 0.92$. It also says that we need to spend double the present health budget on vaccines after the support is withdrawn. The study states that the recipient countries need to develop a financial stability programme when they need to fund the initiative 100%.

... The question is: will GAVI transfer the technology of pentavalent vaccine manufacturing to these three public sector units?

[Read more]

Comment on this post by email or on the web

Conseil Sante is a French consulting company providing technical assistance to ministries of health and governmental bodies in the field of health. As part of a tender process for a mid-term evaluation project, we are looking for a Vietnamese technician in cold chain maintenance.

[Read more]

Comment on this post by email or on the web